|
|
Line 1: |
Line 1: |
| __NOTOC__ | | __NOTOC__ |
| | |
| {{CMG}}; {{AE}}{{EG}} | | {{CMG}}; {{AE}}{{EG}} |
|
| |
|
Line 39: |
Line 40: |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Other | | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Other |
| |- | | |- |
| ! rowspan="22" style="background: #DCDCDC; padding: 5px; text-align: center;" |Prerenal causes | | ! rowspan="8" style="background: #DCDCDC; padding: 5px; text-align: center;" |Prerenal causes |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Alcohol poisoning]]<ref name="pmid15589492">{{cite journal |vauthors=Pletcher MJ, Maselli J, Gonzales R |title=Uncomplicated alcohol intoxication in the emergency department: an analysis of the National Hospital Ambulatory Medical Care Survey |journal=Am. J. Med. |volume=117 |issue=11 |pages=863–7 |date=December 2004 |pmid=15589492 |doi=10.1016/j.amjmed.2004.07.042 |url=}}</ref><ref name="pmid2927129">{{cite journal |vauthors=Cherpitel CJ |title=Breath analysis and self-reports as measures of alcohol-related emergency room admissions |journal=J. Stud. Alcohol |volume=50 |issue=2 |pages=155–61 |date=March 1989 |pmid=2927129 |doi= |url=}}</ref> | | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Alcohol poisoning]]<ref name="pmid15589492">{{cite journal |vauthors=Pletcher MJ, Maselli J, Gonzales R |title=Uncomplicated alcohol intoxication in the emergency department: an analysis of the National Hospital Ambulatory Medical Care Survey |journal=Am. J. Med. |volume=117 |issue=11 |pages=863–7 |date=December 2004 |pmid=15589492 |doi=10.1016/j.amjmed.2004.07.042 |url=}}</ref><ref name="pmid2927129">{{cite journal |vauthors=Cherpitel CJ |title=Breath analysis and self-reports as measures of alcohol-related emergency room admissions |journal=J. Stud. Alcohol |volume=50 |issue=2 |pages=155–61 |date=March 1989 |pmid=2927129 |doi= |url=}}</ref> |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + |
Line 62: |
Line 63: |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Thiamine]] must be given to prevent [[Wernicke's encephalopathy]] | | | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Thiamine]] must be given to prevent [[Wernicke's encephalopathy]] |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Aspergillosis|'''Aspergillosis''']]<ref name="pmid11880955">{{cite journal |vauthors=Marr KA, Carter RA, Crippa F, Wald A, Corey L |title=Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients |journal=Clin. Infect. Dis. |volume=34 |issue=7 |pages=909–17 |date=April 2002 |pmid=11880955 |doi=10.1086/339202 |url=}}</ref><ref name="pmid16886149">{{cite journal |vauthors=Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, Chevrier S, Meunier C, Lebert C, Aupée M, Caulet-Maugendre S, Faucheux M, Lelong B, Leray E, Guiguen C, Gangneux JP |title=Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey |journal=Clin. Infect. Dis. |volume=43 |issue=5 |pages=577–84 |date=September 2006 |pmid=16886149 |doi=10.1086/505870 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Allergy test]], ↑[[IgE]] (>1000 IU/dl), Direct visualization of [[Hyphae|fungal hyphae]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Pulmonary infiltrates, [[Mucus|Mucus plug]], Mass in the upper lobe surrounded by a crescent of air, Solitary or multiple cavities
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Halo sign, Wedge-shaped pulmonary [[infarction]], [[Granuloma]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Polymerase chain reaction|Polymerase chain reaction (PCR)]]
| |
| |- | | |- |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cholera|'''Cholera''']]<ref name="pmid19842974">{{cite journal |vauthors=Weil AA, Khan AI, Chowdhury F, Larocque RC, Faruque AS, Ryan ET, Calderwood SB, Qadri F, Harris JB |title=Clinical outcomes in household contacts of patients with cholera in Bangladesh |journal=Clin. Infect. Dis. |volume=49 |issue=10 |pages=1473–9 |date=November 2009 |pmid=19842974 |pmc=2783773 |doi=10.1086/644779 |url=}}</ref><ref name="pmid4809112">{{cite journal |vauthors=Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP, Hornick RB |title=Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum |journal=J. Infect. Dis. |volume=129 |issue=1 |pages=45–52 |date=January 1974 |pmid=4809112 |doi= |url=}}</ref><ref name="pmid4809112">{{cite journal |vauthors=Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP, Hornick RB |title=Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum |journal=J. Infect. Dis. |volume=129 |issue=1 |pages=45–52 |date=January 1974 |pmid=4809112 |doi= |url=}}</ref><ref name="pmid21696312">{{cite journal |vauthors=Harris JB, Ivers LC, Ferraro MJ |title=Case records of the Massachusetts General Hospital. Case 19-2011. A 4-year-old Haitian boy with vomiting and diarrhea |journal=N. Engl. J. Med. |volume=364 |issue=25 |pages=2452–61 |date=June 2011 |pmid=21696312 |doi=10.1056/NEJMcpc1100927 |url=}}</ref> | | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cholera|'''Cholera''']]<ref name="pmid19842974">{{cite journal |vauthors=Weil AA, Khan AI, Chowdhury F, Larocque RC, Faruque AS, Ryan ET, Calderwood SB, Qadri F, Harris JB |title=Clinical outcomes in household contacts of patients with cholera in Bangladesh |journal=Clin. Infect. Dis. |volume=49 |issue=10 |pages=1473–9 |date=November 2009 |pmid=19842974 |pmc=2783773 |doi=10.1086/644779 |url=}}</ref><ref name="pmid4809112">{{cite journal |vauthors=Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP, Hornick RB |title=Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum |journal=J. Infect. Dis. |volume=129 |issue=1 |pages=45–52 |date=January 1974 |pmid=4809112 |doi= |url=}}</ref><ref name="pmid4809112">{{cite journal |vauthors=Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP, Hornick RB |title=Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum |journal=J. Infect. Dis. |volume=129 |issue=1 |pages=45–52 |date=January 1974 |pmid=4809112 |doi= |url=}}</ref><ref name="pmid21696312">{{cite journal |vauthors=Harris JB, Ivers LC, Ferraro MJ |title=Case records of the Massachusetts General Hospital. Case 19-2011. A 4-year-old Haitian boy with vomiting and diarrhea |journal=N. Engl. J. Med. |volume=364 |issue=25 |pages=2452–61 |date=June 2011 |pmid=21696312 |doi=10.1056/NEJMcpc1100927 |url=}}</ref> |
Line 201: |
Line 179: |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Esophageal varices|'''Esophageal varices bleeding''']]<ref name="pmid6970703">{{cite journal |vauthors=Graham DY, Smith JL |title=The course of patients after variceal hemorrhage |journal=Gastroenterology |volume=80 |issue=4 |pages=800–9 |date=April 1981 |pmid=6970703 |doi= |url=}}</ref><ref name="pmid20638742">{{cite journal |vauthors=de Franchis R |title=Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension |journal=J. Hepatol. |volume=53 |issue=4 |pages=762–8 |date=October 2010 |pmid=20638742 |doi=10.1016/j.jhep.2010.06.004 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Normocytic normochromic anemia]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Velocity and direction of [[portal]] flow
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Abnormal opacities outside of[[esophageal]] wall, Posterior [[mediastinal]] or intraparenchymal mass, Dilated [[azygous vein]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Entire portal venous system
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Portrays [[esophageal varices]] as flow voids
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Portal hypertension and [[esophageal varices]] in [[positron emission tomography]], Flexible [[endoscope]], [[Barium swallow]] of snake-like filling defects
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Heart disease]]<ref name="pmid2030718">{{cite journal |vauthors=LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb JD, Evans D, Hennekens CH |title=Smoking and mortality among older men and women in three communities |journal=N. Engl. J. Med. |volume=324 |issue=23 |pages=1619–25 |date=June 1991 |pmid=2030718 |doi=10.1056/NEJM199106063242303 |url=}}</ref><ref name="pmid19581259">{{cite journal |vauthors=Mahle WT, Newburger JW, Matherne GP, Smith FC, Hoke TR, Koppel R, Gidding SS, Beekman RH, Grosse SD |title=Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP |journal=Pediatrics |volume=124 |issue=2 |pages=823–36 |date=August 2009 |pmid=19581259 |doi=10.1542/peds.2009-1397 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[ESR]] and [[CRP]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Throat culture]], Rapid streptococcal antigen test, Hyperoxia test, [[Pulse oximetry]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Cardiomegaly]], [[Dextrocardia]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Ventricular dysfunction]], Left and right ventricular [[hypertrophy]], Valvular disease in [[echocardiography]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemorrhage]]<ref name="pmid21098468">{{cite journal |vauthors=Achneck HE, Sileshi B, Parikh A, Milano CA, Welsby IJ, Lawson JH |title=Pathophysiology of bleeding and clotting in the cardiac surgery patient: from vascular endothelium to circulatory assist device surface |journal=Circulation |volume=122 |issue=20 |pages=2068–77 |date=November 2010 |pmid=21098468 |doi=10.1161/CIRCULATIONAHA.110.936773 |url=}}</ref><ref name="pmid3487361">{{cite journal |vauthors=Gralnick HR, Rick ME, McKeown LP, Williams SB, Parker RI, Maisonneuve P, Jenneau C, Sultan Y |title=Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease |journal=Blood |volume=68 |issue=1 |pages=58–61 |date=July 1986 |pmid=3487361 |doi= |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Normocytic normochromic anemia]], ↑[[PT]], ↑[[PTT]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Sodium|Na]], ↑[[Chloride|Cl]], ↓[[Ca]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Metabolic acidosis]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Peritoneal cavity fluid in [[FAST]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Bilateral opacities in the lung field, [[Hemothorax]], Hemoperitoneum, Ruptured [[abdominal aortic aneurysm]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Intrathoracic, intra-abdominal, and retroperitoneal [[bleeding]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Source of [[bleeding]] in the upper GI in [[Esophagogastroduodenoscopy|EGD]], [[Angiography]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemolysis]]<ref name="pmid3814817">{{cite journal |vauthors=Liesveld JL, Rowe JM, Lichtman MA |title=Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases |journal=Blood |volume=69 |issue=3 |pages=820–6 |date=March 1987 |pmid=3814817 |doi= |url=}}</ref><ref name="pmid7365971">{{cite journal |vauthors=Marchand A, Galen RS, Van Lente F |title=The predictive value of serum haptoglobin in hemolytic disease |journal=JAMA |volume=243 |issue=19 |pages=1909–11 |date=May 1980 |pmid=7365971 |doi= |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Thrombocytopenia|Thrombocytopenia,]] [[Microcytic anemia|Microcytic hypochromic anemia]], ↑RDW, ↑[[Reticulocyte|Retic]] count
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[LDH]], ↓[[Haptoglobin]], ↑Unconjugated [[bilirubin]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Hepatomegaly]],[[Splenomegaly]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| |-
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Etiology
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Fatigue/
| |
| Lethargy
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Thirst
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Dizziness/
| |
| Confusion
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Muscle weakness/
| |
| cramp
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Somatic/
| |
| visceral pain
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Vomiting
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Diarrhea
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Tachypnea
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Edema
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Blood indices
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Renal Funtion test
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Electrolytes
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Urine analysis
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |ABG
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Other
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Ultrasound
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |X-ray
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |CT
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |MRI
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Other
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Comments
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hepatorenal syndrome]]<ref name="pmid19776409">{{cite journal |vauthors=Ginès P, Schrier RW |title=Renal failure in cirrhosis |journal=N. Engl. J. Med. |volume=361 |issue=13 |pages=1279–90 |date=September 2009 |pmid=19776409 |doi=10.1056/NEJMra0809139 |url=}}</ref><ref name="pmid8550036">{{cite journal |vauthors=Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Schölmerich J |title=Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club |journal=Hepatology |volume=23 |issue=1 |pages=164–76 |date=January 1996 |pmid=8550036 |doi=10.1002/hep.510230122 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Leukocytosis]], ↑[[PT]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Glomerular filtration rate|GFR]], ↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Proteinuria]], [[Sodium|Na]] < 10 mEq/L, [[Urine osmolality]] > [[plasma osmolality]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Alpha fetoprotein|Alpha feto-protein]], [[Cryoglobulinemia]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Exclude [[hydronephrosis]] and intrinsic renal disease
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Right ventricular preload, ventricular filling pressures, and cardiac function in [[echocardiography]]
| |
| | -
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cardiomyopathy|Ischemic cardiomyopathy]]<ref name="pmid16567565">{{cite journal |vauthors=Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB |title=Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention |journal=Circulation |volume=113 |issue=14 |pages=1807–16 |date=April 2006 |pmid=16567565 |doi=10.1161/CIRCULATIONAHA.106.174287 |url=}}</ref><ref name="pmid15689345">{{cite journal |vauthors=Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, Panhuyzen-Goedkoop N, Deligiannis A, Solberg E, Dugmore D, Mellwig KP, Assanelli D, Delise P, van-Buuren F, Anastasakis A, Heidbuchel H, Hoffmann E, Fagard R, Priori SG, Basso C, Arbustini E, Blomstrom-Lundqvist C, McKenna WJ, Thiene G |title=Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology |journal=Eur. Heart J. |volume=26 |issue=5 |pages=516–24 |date=March 2005 |pmid=15689345 |doi=10.1093/eurheartj/ehi108 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Anemia]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Cr]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]], ↓[[Potassium|K]], ↓[[Magnesium|Mg]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Troponin]], [[Creatine kinase]], [[Creatine kinase]] - MB, [[Brain natriuretic peptide|BNP]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Abnormal cardiac silhouette
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Biventricular volume, Wall motion abnormality, Myocardial perfusion, [[Hypertrophic cardiomyopathy]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Mid-wall [[fibrosis]] in [[MRI]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Ejection fraction ≤35%, Pulmonary embolism, Right ventricular dilation or [[pericardial effusion]] with tamponade in echocardiography
| |
| | -
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Liver cirrhosis]]<ref name="pmid24076364">{{cite journal |vauthors=Ge PS, Runyon BA |title=The changing role of beta-blocker therapy in patients with cirrhosis |journal=J. Hepatol. |volume=60 |issue=3 |pages=643–53 |date=March 2014 |pmid=24076364 |doi=10.1016/j.jhep.2013.09.016 |url=}}</ref><ref name="pmid3533689">{{cite journal |vauthors=Becker CD, Scheidegger J, Marincek B |title=Hepatic vein occlusion: morphologic features on computed tomography and ultrasonography |journal=Gastrointest Radiol |volume=11 |issue=4 |pages=305–11 |date=1986 |pmid=3533689 |doi= |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Liver function tests|LFT]], [[Aspartate aminotransferase]] to [[platelet]] ratio, FibroTest/FibroSure, Hepascore, FibroSpectatio
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Portal blood flow velocity, [[Hepatic artery]] enlargement, Multifocal lesions or masses, Hepatic contour, [[Ascites]], [[Splenomegaly]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Bowel perforation]], [[Gynecomastia]], [[Azygos vein]] enlargement, [[Pleural effusion]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Morphologic changes in the liver, Collaterals and shunts, Hyperattenuating nodule of [[hepatocellular carcinoma]], [[Portal vein thrombosis]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Vacular patency, Tumor invasion, [[Portal vein thrombosis]], [[Steatosis]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Hepatic]] function and [[portal hypertension]] in nuclear imaging, [[Hepatic]] perfusion and the development of [[shunt]]s and [[tumor]]s in angiography
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Irreversible and a transplant is usually needed
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Malignant hypertension]]<ref name="pmid23102030">{{cite journal |vauthors=Johnson W, Nguyen ML, Patel R |title=Hypertension crisis in the emergency department |journal=Cardiol Clin |volume=30 |issue=4 |pages=533–43 |date=November 2012 |pmid=23102030 |doi=10.1016/j.ccl.2012.07.011 |url=}}</ref><ref name="pmid16627047">{{cite journal |vauthors=Elliott WJ |title=Clinical features in the management of selected hypertensive emergencies |journal=Prog Cardiovasc Dis |volume=48 |issue=5 |pages=316–25 |date=2006 |pmid=16627047 |doi=10.1016/j.pcad.2006.02.004 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Microangiopathic hemolytic anemia]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Sodium|Na]], ↑[[Potassium|K]], ↑[[Phosphate|P]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Proteinuria]], [[Microscopic hematuria]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Acidosis]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Cardiac enzymes]], Urinary [[catecholamines]], [[TSH]], ↑[[Renin]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Cardiomegaly, [[Pulmonary edema]], Rib notching, [[Aortic coarctation]], Mediastinal widening, [[Aortic dissection]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Left atrial enlargement and left ventricular [[hypertrophy|hypertrophy in]] [[echocardiography]]
| |
| | -
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Myocarditis]]<ref name="pmid39746742">{{cite journal |vauthors=Dec GW, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA |title=Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome |journal=N. Engl. J. Med. |volume=312 |issue=14 |pages=885–90 |date=April 1985 |pmid=3974674 |doi=10.1056/NEJM198504043121404 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Leukocytosis]] ([[eosinophilia]]),↑[[ESR]] and [[CRP]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Cardiac enzymes]], Viral antibodies
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Inflammatory [[edema]], Degree of scarring
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Endomyocardial biopsy]], [[Echocardiography]], [[Scintigraphy]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| |- | | |- |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Peritonitis]]<ref name="pmid97980132">{{cite journal |vauthors=Such J, Runyon BA |title=Spontaneous bacterial peritonitis |journal=Clin. Infect. Dis. |volume=27 |issue=4 |pages=669–74; quiz 675–6 |date=October 1998 |pmid=9798013 |doi= |url=}}</ref><ref name="pmid22106722">{{cite journal |vauthors=Runyon BA |title=Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis |journal=Hepatology |volume=12 |issue=4 Pt 1 |pages=710–5 |date=October 1990 |pmid=2210672 |doi= |url=}}</ref> | | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Peritonitis]]<ref name="pmid97980132">{{cite journal |vauthors=Such J, Runyon BA |title=Spontaneous bacterial peritonitis |journal=Clin. Infect. Dis. |volume=27 |issue=4 |pages=669–74; quiz 675–6 |date=October 1998 |pmid=9798013 |doi= |url=}}</ref><ref name="pmid22106722">{{cite journal |vauthors=Runyon BA |title=Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis |journal=Hepatology |volume=12 |issue=4 Pt 1 |pages=710–5 |date=October 1990 |pmid=2210672 |doi= |url=}}</ref> |
Line 455: |
Line 199: |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polycythemia]]<ref name="pmid90251652">{{cite journal |vauthors=Gregg XT, Prchal JT |title=Erythropoietin receptor mutations and human disease |journal=Semin. Hematol. |volume=34 |issue=1 |pages=70–6 |date=January 1997 |pmid=9025165 |doi= |url=}}</ref><ref name="pmid92925432">{{cite journal |vauthors=Kralovics R, Indrak K, Stopka T, Berman BW, Prchal JF, Prchal JT |title=Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias |journal=Blood |volume=90 |issue=5 |pages=2057–61 |date=September 1997 |pmid=9292543 |doi= |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[RBC]], ↑[[Hematocrit|HCT]], ↑[[Hemoglobin|HGB]], [[Thrombocytosis]], [[Leukocytosis]], ↑[[PT]] and [[aPTT]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Erythropoietin]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Hyperuricemia]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Splenomegaly]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Phlebotomy]] is the usual treatment
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Respiratory distress syndrome]]<ref name="pmid265428772">{{cite journal |vauthors=Hooper SB, Te Pas AB, Kitchen MJ |title=Respiratory transition in the newborn: a three-phase process |journal=Arch. Dis. Child. Fetal Neonatal Ed. |volume=101 |issue=3 |pages=F266–71 |date=May 2016 |pmid=26542877 |doi=10.1136/archdischild-2013-305704 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Metabolic acidosis|Metabolic]] and [[Metabolic acidosis|respiratory acidosis]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Pulse oximetry]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Bilateral, diffuse, reticular granular or ground-glass appearance +/- [[Cardiomegaly]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Patent ductus arteriosus]] [[hypertrophy|in]] [[echocardiography]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Shock]]<ref name="pmid24171518">{{cite journal |vauthors=Vincent JL, De Backer D |title=Circulatory shock |journal=N. Engl. J. Med. |volume=369 |issue=18 |pages=1726–34 |date=October 2013 |pmid=24171518 |doi=10.1056/NEJMra1208943 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Hematocrit|HCT]], ↑[[PT]] and [[aPTT]], [[Eosinophilia]], [[Leukocytosis]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Glomerular filtration rate|GFR]], ↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Lactate]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Liver function tests|LFT]], ↑[[BNP]], ↑[[Troponin]], [[D-dimer]], [[Fibrinogen]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Pulmonary embolism]], [[Pericardial effusion]], [[Cardiac tamponade]], [[Pneumothorax]], Thoracic or [[abdominal aortic aneurysm]] in RUSH (Rapid Ultrasound for Shock and Hypotension)
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Pneumonia]], [[Pneumothorax]], [[Pulmonary edema]], Widened [[mediastinum]], Free air under the [[diaphragm]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Traumatic brain injury, [[Stroke]], Spinal injury, [[Pneumonia]], [[Pneumothorax]], Ruptured [[aneurysm]], [[Aortic dissection]], [[Pulmonary embolism]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - |
Line 551: |
Line 226: |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - |
| |- | | |- |
| ! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Etiology | | ! rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Renal causes |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Fatigue/
| |
| Lethargy
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Thirst
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Dizziness/
| |
| Confusion
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Muscle weakness/
| |
| cramp
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Somatic/
| |
| visceral pain
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Vomiting
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Diarrhea
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Tachypnea
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Edema
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Blood indices
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Renal Funtion test
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Electrolytes
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Urine analysis
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |ABG
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Other
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Ultrasound
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |X-ray
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |CT
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |MRI
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Other
| |
| ! align="center" style="background:#4479BA; color: #FFFFFF;" |Comments
| |
| |-
| |
| ! rowspan="10" style="background: #DCDCDC; padding: 5px; text-align: center;" |Renal causes
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Acute interstitial nephritis]]<ref name="pmid11020015">{{cite journal |vauthors=Schwarz A, Krause PH, Kunzendorf U, Keller F, Distler A |title=The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis |journal=Clin. Nephrol. |volume=54 |issue=3 |pages=179–90 |date=September 2000 |pmid=11020015 |doi= |url=}}</ref><ref name="pmid20336051">{{cite journal |vauthors=Praga M, González E |title=Acute interstitial nephritis |journal=Kidney Int. |volume=77 |issue=11 |pages=956–61 |date=June 2010 |pmid=20336051 |doi=10.1038/ki.2010.89 |url=}}</ref> | | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Acute interstitial nephritis]]<ref name="pmid11020015">{{cite journal |vauthors=Schwarz A, Krause PH, Kunzendorf U, Keller F, Distler A |title=The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis |journal=Clin. Nephrol. |volume=54 |issue=3 |pages=179–90 |date=September 2000 |pmid=11020015 |doi= |url=}}</ref><ref name="pmid20336051">{{cite journal |vauthors=Praga M, González E |title=Acute interstitial nephritis |journal=Kidney Int. |volume=77 |issue=11 |pages=956–61 |date=June 2010 |pmid=20336051 |doi=10.1038/ki.2010.89 |url=}}</ref> |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> |
Line 601: |
Line 249: |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |History of long term [[analgesic]] use | | | style="background: #F5F5F5; padding: 5px; text-align: center;" |History of long term [[analgesic]] use |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Acute tubular necrosis]]<ref name="pmid22890468">{{cite journal |vauthors=Khwaja A |title=KDIGO clinical practice guidelines for acute kidney injury |journal=Nephron Clin Pract |volume=120 |issue=4 |pages=c179–84 |date=2012 |pmid=22890468 |doi=10.1159/000339789 |url=}}</ref><ref name="pmid15680458">{{cite journal |vauthors=Lameire N, Van Biesen W, Vanholder R |title=Acute renal failure |journal=Lancet |volume=365 |issue=9457 |pages=417–30 |date=2005 |pmid=15680458 |doi=10.1016/S0140-6736(05)17831-3 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Anemia]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]], ↑[[Fractional sodium excretion|FENa]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]], ↑[[Potassium|K]], ↑[[Magnesium|Mg]], ↑[[Phosphate|P]], ↓[[Calcium|Ca]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Pigmented, muddy brown, granular casts
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Obstructive uropathy]], Renal size, Cortical thickness, [[Hydronephrosis]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Nephrolithiasis]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Nephrolithiasis]], Area of [[obstruction]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Nephrolithiasis]], Area of [[obstruction]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Loss of [[Tubular|tubular cells]] or the denuded tubules, Swollen [[Tubular|tubular cells]], Loss of the cell brush border in [[Kidney|renal biopsy]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Furosemide]] stress testing for staging
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cancer]]<ref name="pmid16360438">{{cite journal |vauthors=Gudbjartsson T, Thoroddsen A, Petursdottir V, Hardarson S, Magnusson J, Einarsson GV |title=Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients |journal=Urology |volume=66 |issue=6 |pages=1186–91 |date=December 2005 |pmid=16360438 |doi=10.1016/j.urology.2005.07.009 |url=}}</ref><ref name="pmid5125665">{{cite journal |vauthors=Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF |title=Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases |journal=Cancer |volume=28 |issue=5 |pages=1165–77 |date=November 1971 |pmid=5125665 |doi= |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Normocytic anemia|Normocytic]] or [[microcytic anemia]], [[Leukocytosis]] or [[lymphocytosis]], ↑[[Reticulocytes]], [[Thrombocytopenia]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Glomerular filtration rate|GFR]], ↑[[Blood urea nitrogen|BUN]], ↑[[Cr]], ↓[[Erythropoietin]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]], ↑[[Potassium|K]], ↓[[Magnesium|Mg]], ↑[[Phosphate|P]], ↓[[Calcium|Ca]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Gross [[hematuria]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Liver function tests|LFT]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Fluid collection and morphological change, Flank mass
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Calcification]] and widened mediastinum, Filling defects in [[Barium|barium contrast]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Metastasis and [[Cancer staging|staging]], Cystic and solid masses, [[Lymph node]], [[renal vein]], and [[inferior vena cava]] involvement
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Soft tissue]] invasion and [[Cancer staging|staging]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Malignant]] cystic lesions [[percutaneous]] cyst puncture
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Renal cell carcinoma]] types: [[Clear cell]] (75%), Chromophilic (15%), [[Chromophobic]] (5%), [[Oncocytoma]] (3%), [[Collecting duct]] (2%)
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Congenital disease|'''Congenital kidney disease''']]<ref name="pmid12197558">{{cite journal |vauthors=Queisser-Luft A, Stolz G, Wiesel A, Schlaefer K, Spranger J |title=Malformations in newborn: results based on 30,940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990-1998) |journal=Arch. Gynecol. Obstet. |volume=266 |issue=3 |pages=163–7 |date=July 2002 |pmid=12197558 |doi= |url=}}</ref><ref name="pmid19536081">{{cite journal |vauthors=Sanna-Cherchi S, Ravani P, Corbani V, Parodi S, Haupt R, Piaggio G, Innocenti ML, Somenzi D, Trivelli A, Caridi G, Izzi C, Scolari F, Mattioli G, Allegri L, Ghiggeri GM |title=Renal outcome in patients with congenital anomalies of the kidney and urinary tract |journal=Kidney Int. |volume=76 |issue=5 |pages=528–33 |date=September 2009 |pmid=19536081 |doi=10.1038/ki.2009.220 |url=}}</ref><ref name="pmid11992035">{{cite journal |vauthors=Glassberg KI |title=Normal and abnormal development of the kidney: a clinician's interpretation of current knowledge |journal=J. Urol. |volume=167 |issue=6 |pages=2339–50; discussion 2350–1 |date=June 2002 |pmid=11992035 |doi= |url=}}</ref>
| |
| - [[Agenesis]]
| |
|
| |
| - [[Dysplasia]]
| |
|
| |
| - [[Hypoplasia]]
| |
|
| |
| - [[Polycystic kidney disease|Polycystic]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Hematocrit|HCT]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Glomerular filtration rate|GFR]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Phosphate|P]], ↓[[Calcium|Ca]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Microalbuminuria]], [[Uricosuria]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Genetic testing for[[Autosomal dominant polycystic kidney disease|ADPKD2]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Visualization of [[Cysts|kidney cysts]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Small kidney cysts (0.5 cm)
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Kidney]] size, [[Intracranial aneurysms]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[End stage renal disease]]<ref name="pmid20054047">{{cite journal |vauthors=Abboud H, Henrich WL |title=Clinical practice. Stage IV chronic kidney disease |journal=N. Engl. J. Med. |volume=362 |issue=1 |pages=56–65 |date=January 2010 |pmid=20054047 |doi=10.1056/NEJMcp0906797 |url=}}</ref><ref name="pmid28614683">{{cite journal |vauthors=Denic A, Mathew J, Lerman LO, Lieske JC, Larson JJ, Alexander MP, Poggio E, Glassock RJ, Rule AD |title=Single-Nephron Glomerular Filtration Rate in Healthy Adults |journal=N. Engl. J. Med. |volume=376 |issue=24 |pages=2349–2357 |date=June 2017 |pmid=28614683 |pmc=5664219 |doi=10.1056/NEJMoa1614329 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Anemia]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Glomerular filtration rate|GFR]], ↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Potassium|K]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Hypoalbuminuria]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Bicarbonate|HCO3]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Phosphate]], [[25-hydroxy vitamin D]], [[Alkaline phosphatase]], [[Parathyroid hormone]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Hydronephrosis]], [[Retroperitoneal fibrosis]], Enlarged or shrunken [[kidneys]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |
| |
| *[[Obstruction]] in [[retrograde pyelogram]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Renal masses, [[Kidney stone|stones]], and [[cysts]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Renal vein thrombosis]], [[Renal artery stenosis]] in magnetic resonance [[angiography]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Percutaneous renal [[biopsy]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Toxin|'''Endogenous toxins''']]<ref name="pmid20533382">{{cite journal |vauthors=Borowitz MJ, Craig FE, Digiuseppe JA, Illingworth AJ, Rosse W, Sutherland DR, Wittwer CT, Richards SJ |title=Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry |journal=Cytometry B Clin Cytom |volume=78 |issue=4 |pages=211–30 |date=July 2010 |pmid=20533382 |doi=10.1002/cyto.b.20525 |url=}}</ref><ref name="pmid6282181">{{cite journal |vauthors=Knochel JP |title=Rhabdomyolysis and myoglobinuria |journal=Annu. Rev. Med. |volume=33 |issue= |pages=435–43 |date=1982 |pmid=6282181 |doi=10.1146/annurev.me.33.020182.002251 |url=}}</ref><ref name="pmid17338959">{{cite journal |vauthors=Giannoglou GD, Chatzizisis YS, Misirli G |title=The syndrome of rhabdomyolysis: Pathophysiology and diagnosis |journal=Eur. J. Intern. Med. |volume=18 |issue=2 |pages=90–100 |date=March 2007 |pmid=17338959 |doi=10.1016/j.ejim.2006.09.020 |url=}}</ref><ref name="pmid6645213">{{cite journal |vauthors=Coe FL |title=Uric acid and calcium oxalate nephrolithiasis |journal=Kidney Int. |volume=24 |issue=3 |pages=392–403 |date=September 1983 |pmid=6645213 |doi= |url=}}</ref><ref name="pmid15202612">{{cite journal |vauthors=Maalouf NM, Cameron MA, Moe OW, Sakhaee K |title=Novel insights into the pathogenesis of uric acid nephrolithiasis |journal=Curr. Opin. Nephrol. Hypertens. |volume=13 |issue=2 |pages=181–9 |date=March 2004 |pmid=15202612 |doi= |url=}}</ref>
| |
| - [[Hemoglobin]]
| |
|
| |
| - [[Myoglobin]]
| |
|
| |
| - [[Uric acid]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Anemia|Anemia,]] [[Thrombocytopenia]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Glomerular filtration rate|GFR]], ↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Potassium|K]], ↑[[Urate]], ↓[[Calcium|Ca]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Uricosuria]], [[Hematuria]], [[Myoglobinuria]], [[Urinary casts|Casts]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Creatine kinase]] > 1000 U/L
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Malignant or cystic lesions, [[Hydronephrosis]], [[Nephrocalcinosis]], [[Urolithiasis]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Urolithiasis]], [[Wilms tumor]], [[Polycystic kidney disease]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Ureter]] or [[Urinary bladder|bladder]] abnormality in voiding cystourethrography
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Glomerulonephritis]]<ref name="pmid2915517">{{cite journal |vauthors=Ellis EN, Mauer SM, Sutherland DE, Steffes MW |title=Glomerular capillary morphology in normal humans |journal=Lab. Invest. |volume=60 |issue=2 |pages=231–6 |date=February 1989 |pmid=2915517 |doi= |url=}}</ref><ref name="pmid27373970">{{cite journal |vauthors=Dickinson BL |title=Unraveling the immunopathogenesis of glomerular disease |journal=Clin. Immunol. |volume=169 |issue= |pages=89–97 |date=August 2016 |pmid=27373970 |doi=10.1016/j.clim.2016.06.011 |url=}}</ref><ref name="pmid7955787">{{cite journal |vauthors=Trachtman H, Bergwerk A, Gauthier B |title=Isolated proteinuria in children. Natural history and indications for renal biopsy |journal=Clin Pediatr (Phila) |volume=33 |issue=8 |pages=468–72 |date=August 1994 |pmid=7955787 |doi=10.1177/000992289403300804 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Pleocytosis]], [[Anemia]], [[Leukocytosis]], ↑[[ESR]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Specific gravity (kidney)|Specific gravity]] > 1.020, [[Proteinuria]], [[Hematuria]], [[Red blood cell]] casts, [[White blood cell]] casts, Cellular casts, Oval fat bodies
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[C3 (complement)|C3]], ↑[[C4A|C4]], ↑[[CH|CH50]], [[Blood culture|Blood]] and tissue culture, [[Antinuclear antibodies]], [[Cryoglobulin]]s,[[Hepatitis B]] and C [[Serological testing|serologies]], [[Antineutrophil cytoplasmic antibody]] ([[ANCA]])
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Kidney size, Echogenicity of the renal cortex, Obstruction, Degree of [[fibrosis]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Pulmonary congestion]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Visceral [[abscesses]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Renal [[biopsy]], Light and electron microscopy, Immunofluorescence aid diagnosis
| |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Goodpasture syndrome]]<ref name="pmid12969182">{{cite journal |vauthors=Pusey CD |title=Anti-glomerular basement membrane disease |journal=Kidney Int. |volume=64 |issue=4 |pages=1535–50 |date=October 2003 |pmid=12969182 |doi=10.1046/j.1523-1755.2003.00241.x |url=}}</ref><ref name="pmid8914046">{{cite journal |vauthors=Bolton WK |title=Goodpasture's syndrome |journal=Kidney Int. |volume=50 |issue=5 |pages=1753–66 |date=November 1996 |pmid=8914046 |doi= |url=}}</ref><ref name="pmid8589284">{{cite journal |vauthors=Kalluri R, Wilson CB, Weber M, Gunwar S, Chonko AM, Neilson EG, Hudson BG |title=Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome |journal=J. Am. Soc. Nephrol. |volume=6 |issue=4 |pages=1178–85 |date=October 1995 |pmid=8589284 |doi= |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Anemia]], [[Leukocytosis|Leukocytosis, ↑]][[ESR]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Low-grade [[proteinuria]], Gross or [[microscopic hematuria]], [[RBC casts]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Anti– glomerular [[basement membrane]] antibody [[Anti-neutrophil cytoplasmic antibody|Antineutrophilic cytoplasmic antibody]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Bilateral, basal, patchy [[Consolidation (medicine)|parenchymal consolidations]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Diffuse [[alveolar]] [[Hemorrhages|hemorrhage]] in [[pulmonary]] [[biopsy]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| |- | | |- |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemolytic uremic syndrome]]<ref name="pmid15728781">{{cite journal |vauthors=Noris M, Remuzzi G |title=Hemolytic uremic syndrome |journal=J. Am. Soc. Nephrol. |volume=16 |issue=4 |pages=1035–50 |date=April 2005 |pmid=15728781 |doi=10.1681/ASN.2004100861 |url=}}</ref><ref name="pmid27989322">{{cite journal |vauthors=Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Frémeaux-Bacchi V, Kavanagh D, Nester CM, Noris M, Pickering MC, Rodríguez de Córdoba S, Roumenina LT, Sethi S, Smith RJ |title=Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference |journal=Kidney Int. |volume=91 |issue=3 |pages=539–551 |date=March 2017 |pmid=27989322 |doi=10.1016/j.kint.2016.10.005 |url=}}</ref><ref name="pmid25859752">{{cite journal |vauthors=Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Frémeaux-Bacchi V |title=An international consensus approach to the management of atypical hemolytic uremic syndrome in children |journal=Pediatr. Nephrol. |volume=31 |issue=1 |pages=15–39 |date=January 2016 |pmid=25859752 |doi=10.1007/s00467-015-3076-8 |url=}}</ref> | | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemolytic uremic syndrome]]<ref name="pmid15728781">{{cite journal |vauthors=Noris M, Remuzzi G |title=Hemolytic uremic syndrome |journal=J. Am. Soc. Nephrol. |volume=16 |issue=4 |pages=1035–50 |date=April 2005 |pmid=15728781 |doi=10.1681/ASN.2004100861 |url=}}</ref><ref name="pmid27989322">{{cite journal |vauthors=Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Frémeaux-Bacchi V, Kavanagh D, Nester CM, Noris M, Pickering MC, Rodríguez de Córdoba S, Roumenina LT, Sethi S, Smith RJ |title=Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference |journal=Kidney Int. |volume=91 |issue=3 |pages=539–551 |date=March 2017 |pmid=27989322 |doi=10.1016/j.kint.2016.10.005 |url=}}</ref><ref name="pmid25859752">{{cite journal |vauthors=Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Frémeaux-Bacchi V |title=An international consensus approach to the management of atypical hemolytic uremic syndrome in children |journal=Pediatr. Nephrol. |volume=31 |issue=1 |pages=15–39 |date=January 2016 |pmid=25859752 |doi=10.1007/s00467-015-3076-8 |url=}}</ref> |
Line 798: |
Line 272: |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Diffuse thickening of the [[glomerular]] capillary wall, Swelling of [[endothelial cells]], [[Fibrin]] [[thrombi]] in renal [[biopsy]] | | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Diffuse thickening of the [[glomerular]] capillary wall, Swelling of [[endothelial cells]], [[Fibrin]] [[thrombi]] in renal [[biopsy]] |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - |
| |-
| |
| ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Nephrolithiasis]]<ref name="pmid23283137">{{cite journal |vauthors=Fwu CW, Eggers PW, Kimmel PL, Kusek JW, Kirkali Z |title=Emergency department visits, use of imaging, and drugs for urolithiasis have increased in the United States |journal=Kidney Int. |volume=83 |issue=3 |pages=479–86 |date=March 2013 |pmid=23283137 |pmc=3587650 |doi=10.1038/ki.2012.419 |url=}}</ref><ref name="pmid26349951">{{cite journal |vauthors=Singh P, Enders FT, Vaughan LE, Bergstralh EJ, Knoedler JJ, Krambeck AE, Lieske JC, Rule AD |title=Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community |journal=Mayo Clin. Proc. |volume=90 |issue=10 |pages=1356–65 |date=October 2015 |pmid=26349951 |pmc=4593754 |doi=10.1016/j.mayocp.2015.07.016 |url=}}</ref><ref name="pmid14960744">{{cite journal |vauthors=Teichman JM |title=Clinical practice. Acute renal colic from ureteral calculus |journal=N. Engl. J. Med. |volume=350 |issue=7 |pages=684–93 |date=February 2004 |pmid=14960744 |doi=10.1056/NEJMcp030813 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Mild [[leukocytosis]], ↑[[CRP]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Sodium|Na]], ↑[[Potassium|K]], ↑[[Phosphate|P]], ↑[[Calcium|Ca]], ↑[[Urate]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Gross or [[microscopic hematuria]], [[Red blood cell]]s, Urinary crystals of [[calcium oxalate]], [[uric acid]], or [[cystine]], [[Hypercalciuria]], Urinary pH > 7 in [[Struvite|struvite stones]] ([[Proteus]], [[Pseudomonas]], [[Klebsiella]]), Urinary pH < 5 in [[uric acid]] stones
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Bicarbonate|HCO3]], [[Renal tubular acidosis]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |All types of stones are visible, [[Hydronephrosis]], [[Abdominal aortic aneurysm]], [[Cholelithiasis]]
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Calcium]] - containing stones, [[Uric acid]] or [[cystine]] stones, Stone movement
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Stone density, size and composition, [[Hydronephrosis]], Nephromegaly, Perinephric fat streaking
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| |
| | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Intravenous pyelogram|Intravenous pyelography (IVP)]], [[Tomography|Renal tomography]], Nuclear renal scan
| |
| | -
| |
| |} | | |} |
| ==References== | | ==References== |